278 related articles for article (PubMed ID: 24992910)
1. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma.
Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.
Gao XD; Qu JH; Chang XJ; Lu YY; Bai WL; Wang H; Xu ZX; An LJ; Wang CP; Zeng Z; Yang YP
Liver Int; 2014 Jan; 34(1):136-46. PubMed ID: 23875825
[TBL] [Abstract][Full Text] [Related]
3. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
[TBL] [Abstract][Full Text] [Related]
4. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.
Lee YR; Kim G; Lee HW; Tak WY; Park SY; Jang SY; Kweon YO; Park JG; Han YS; Chun JM; Han JR; Hur K
Medicine (Baltimore); 2021 Apr; 100(16):e25552. PubMed ID: 33879706
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
Ramzy II; Omran DA; Hamad O; Shaker O; Abboud A
Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
[TBL] [Abstract][Full Text] [Related]
6. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
8. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
9. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
10. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
11. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
12. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
[TBL] [Abstract][Full Text] [Related]
13. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
[TBL] [Abstract][Full Text] [Related]
15. [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.].
Huang Y; Wei L; Sun AM; Zhao RC; Zhang J; Yang HT; Li B; Sun CJ; Ding XQ; Gao B; Zhong YQ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):883-888. PubMed ID: 28598118
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
Xu B; Di J; Wang Z; Han X; Li Z; Luo X; Zheng Q
Biochem Biophys Res Commun; 2013 Aug; 438(2):324-8. PubMed ID: 23891693
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
19. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
